Product
LPCN 1148
Name
LPCN 1148
1 clinical trial
1 drug
2 indications
Indication
CirrhosisIndication
SarcopeniaClinical trial
A Phase 2, Randomized Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and SarcopeniaStatus: Completed, Estimated PCD: 2023-12-18